Dying or Lying? For-Profit Hospices and End-of-Life Care

S-Tier
Journal: American Economic Review
Year: 2025
Volume: 115
Issue: 1
Pages: 263-94

Authors (4)

Jonathan Gruber (not in RePEc) David H. Howard (not in RePEc) Jetson Leder-Luis (National Bureau of Economic Re...) Theodore L. Caputi (not in RePEc)

Score contribution per author:

2.011 = (α=2.01 / 4 authors) × 4.0x S-tier

α: calibrated so average coauthorship-adjusted count equals average raw count

Abstract

The Medicare hospice program is intended to provide palliative care to terminal patients, but patients with long stays in hospice are highly profitable, motivating concerns about overuse among the Alzheimer's and Dementia (ADRD) population in the rapidly growing for-profit sector. We provide the first causal estimates of the effect of for-profit hospice on patient spending using the entry of for-profit hospices over 20 years. We find hospice has saved money for Medicare by offsetting other expensive care among ADRD patients. As a result, policies limiting hospice use including revenue caps and antifraud lawsuits are distortionary and deter potentially cost-saving admissions.

Technical Details

RePEc Handle
repec:aea:aecrev:v:115:y:2025:i:1:p:263-94
Journal Field
General
Author Count
4
Added to Database
2026-01-25